Middle meningeal artery embolization for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a relatively good ability to carry out daily activities before the hematoma (score 0-3 on the modified Rankin Scale)
- The hematoma (collection of blood) on your brain is at least 10mm thick on a scan
- You have at least one of these risk factors: age 75 or older, taking blood thinners, diabetes, hematoma on both sides of the brain, a specific severity score over 3, large hematoma volume (130ml or more), a midline shift of 8mm or more, or a certain appearance on the CT scan
- Your kidney function (creatinine) is below 1.8 and your platelet count is at least 50,000 with normal blood clotting
- Your life expectancy is expected to be more than 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This study looks at a procedure called middle meningeal artery embolization, which blocks blood flow to the lining of the brain to help treat a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see how well this procedure works for adults.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests adding a drug called bevacizumab (given directly into the blood vessels of the brain) to the standard procedure of middle meningeal artery embolization for a chronic subdural hematoma (a slow blood clot on the brain). The goal is to see if the combination helps reduce the chance of the clot returning.
This trial compares different materials used during a procedure to treat chronic subdural hematoma, a collection of old blood on the brain's surface. The goal is to see which material works best to prevent the blood from coming back.
Hear when a new Endovascular Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.